- Anavex appoints contract research organizations to initiate Phase I/IIa clinical programs, regulatory strategies in Alzheimer's disease
Sources News Release
Resource Type: Article
Published: 2010
Anavex Life Sciences Corp signs a definitive master services agreement with Genesis BioPharma Group and ABX-CRO Advanced Pharmaceutical Services to begin clinical studies and regulatory filings for its lead compound for the treatment of Alzheimer#s.
- Anavex presents data on neuroprotective evidence for ANAVEX 2-73, lead compound for Alzheimer's disease
Sources News Release
Resource Type: Article
Published: 2011
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to provide a summary of its second poster presentation at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled Preclinical development of new tetrahydrofur
- Anavex presents data on potential dual utility of ANAVEX 2-73 in both amyloid and tau pathology
Sources News Release
Resource Type: Article
Published: 2011
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to provide a summary of the first of two poster presentations at the Alzheimer’s Association International Conference (AAIC) held in Paris, entitled “The novel aminotetrahydrofuran deriva
- Anavex raises $1.575 million
Sources News Release
Resource Type: Article
Published: 2011
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that it has raised US$1,575,000.00 through the exercise of warrants. Funds will be used to continue the Phase I clinical trial of ANAVEX 2-73 the company’s lead drug candidate
- Anavex rapidly advances ANAVEX 2-73 for Alzheimer's disease, Phase I clinical trial progressing well
Sources News Release
Resource Type: Article
Published: 2011
Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) has commenced the 30 mg dose step in its ongoing Phase I clinical trial to evaluate ANAVEX 2-73, the company’s lead drug candidate for Alzheimer’s disease. This is the third of six potential dose
- Anavex to present at Alzheimer’s Association International Conference on Alzheimer's Disease
Sources News Release
Resource Type: Article
Published: 2011
Anavex Life Sciences Corp. (“Anavex”) (OTCBB: AVXL) today announced that new data on ANAVEX 2-73, the company’s lead compound for Alzheimer’s disease (AD) currently in Phase I clinical trials, will be presented in two poster sessions at the 2011 Alzh
- Anavex to present at Rodman & Renshaw Healthcare Conference September 13 in New York
Sources News Release
Resource Type: Article
Published: 2010
Anavex Life Sciences Corp. ("ANAVEX") (OTCBB: AVXL) is pleased to announce that Dr. Cameron Durrant, the company#s Executive Chairman, will be presenting at the Rodman & Renshaw 12th Annual Healthcare Conference at 4:45 pm ET on Monday, September 13
- Bad Pharma
How drug companies mislead doctors and harm patients
Resource Type: Book
Published: 2012
Doctors and patients need good scientific evidence to make informed decisions. But instead, companies run bad trials on their own drugs, which distort and exaggerate the benefits by design. When these trials produce unflattering results, the data is simply buried.
- Bad Pharma, Bad Journalism
Resource Type: Article
Published: 2012
‘The drugs don't work: a modern medical scandal’, from Ben Goldacre's new book, Bad Pharma presents a disturbing picture emerges of corporate drug abuse.
- Canadian AIDS Treatment Information Exchange (CATIE)
Media Profile in Sources
Resource Type: Organization
- Connexions
Volume 9, Number 1 - Spring 1984 - Energy - A Digest of Resources and Groups for Social Change
Resource Type: Serial Publication (Periodical)
Published: 1984
- Connexions Library: Health Focus
Resource Type: Website
Selected articles, books, websites and other resources on health.
- Deception By Design
Pharmaceutical Promotion in the Third World
Resource Type: Book
Published: 1996
The authors discuss the workings of the pharmaceutical industry by exposing the unethical marketing practices, double standards and weak marketing codes.
- Don't Blame the Medicine
Use the Drug Expert Pharmacist
Resource Type: Book
Published: 1993
- Drugs & Pharmaceuticals Topic Index in Sources Directory of Experts
Spokespersons, Experts, and Resources
Resource Type: Website
A subject guide to experts and spokespersons on topics related to drugs and pharmaceuticals in the Sources directory for the media.
- Dr. Cameron Durrant, MD, MBA, Alzheimer's Disease and Pharmaceuticals/Biotech Expert
Media Profile in Sources
Resource Type: Organization
- 100 Wörter des Jahrhunderts
Resource Type: Book
Published: 1999
- Genocide by Prescription: The "Natural History" of the Declining White Working Class in America
Resource Type: Article
Published: 2016
The white working class in the US has been decimated through an epidemic of 'premature deaths' -- a bland term to cover-up the drop in life expectancy in this historically important demographic. This is the first time in the country's 'peacetime' history that its traditional core productive sector has experienced such a dramatic demographic decline -- and the epicenter is in the small towns and rural communities of the United States.
- Goodmans LLP
Media Profile in Sources
Resource Type: Organization
- Healthcare in China: GSK claims prompt crackdown on corruption
Resource Type: Article
Published: 2013
Fallout of bribery allegations against British company shows the state wants to be seen to act to clean up murky system.
- HealthSources.ca
Resource Type: Website
Published: 2017
A web portal featuring information and resources about health, with articles, documents, books, websites, and experts and spokespersons. The home page features a selection of recent and important articles. A search feature, subject index, and other research tools make it possible to find additional resources and information.
- Held hostage by Big Pharma: a personal experience
Resource Type: Article
Published: 2013
Mike Marqusee looks at how drug firms can make huge profits from their state-enforced monopoly on an essential good.
- High Society
Legal and Illegal Drugs in Canada
Resource Type: Book
Published: 1991
- Killing 'Schizophrenics': Contemporary U.S. Psychiatry Versus Nazi Psychiatry
Resource Type: Article
Published: 2017
In the United States in the earlier part of the twentieth century, there was widespread compulsory sterilization of those diagnosed with serious mental illness; and from the 1970s through the early 1990s, dehumanizing experiments that ignored the Nuremberg Code of research ethics were administered on this population by prominent American psychiatrists.
- The Medicine Show
Resource Type: Book
- National Senior Safety Week: Drug Safety for Seniors
Sources News Release
Resource Type: Article
Published: 2012
Many older Canadians are on multiple medications to treat a wide spectrum of ailments and improve quality of life. But without taking proper precautions, these life-saving and life-improving drugs can cause sickness and premature death.
- NDMAC, Advancing Canadian Self-care
Media Profile in Sources
Resource Type: Organization
- The No-Nonsense Guide to HIV/AIDS
Resource Type: Book
Published: 2003
This book gives an overview of the origins of HIV, the ways in which it spreads, the profits made by drug companies, women's special vulnerability and the positive action being taken by people and communities to fight back.
- Ontario Takes Legal Action Against Pharmacies, Generic Drug Companies and Wholesalers
Sources News Release
Resource Type: Article
Published: 2009
Ontario is taking legal action against a number of pharmacies, generic drug manufacturers and wholesalers after the discovery of their involvement in a scheme where drug products were being sold several times.
- Outrage Against Big Pharma! Activists Protest "Obscene" Conference
Resource Type: Article
Published: 2016
It was in their fancy tailored suits and with suspicious eyes that Big Pharma CEO's and investors got interrupted by protestors as they came and went from the (too-big-to-fail) JP Morgan-sponsored conference on "health care" (read: profit care) at the elite Westin St. Francis hotel on Union Square in San Francisco on Monday, the 11th of January 2016.
- Patented Medicine Prices Review Board
Media Profile in Sources
Resource Type: Organization
- Pfizer's Elixir of Youth?
Tamoxifen Makes Women Live Longer (Says Manufacturer of Tamoxifen)
Resource Type: Article
Published: 2012
It was a great moment in Pharma funded physician “education.” At a symposium at the American Psychiatric Association’s 2010 meeting called “Mood, Memory and Myths: What Really Happens at Menopause,” two Wyeth/Pfizer funded speakers tried to resurrect the benefits of cancer-linked hormone therapy. But the mostly-female audience was having none of it: what can we do about our “tamoxifen brain” from the cancer we already have, they wanted to know.
- Pharma Funded "Patient" Groups Keep Drug Prices Astronomical
Resource Type: Article
Published: 2017
- Pharma Greed Run Amuk
Resource Type: Article
Published: 2016
Congress, especially its GOP members, created the Martin monster. Martin Shkreli is only one of the monsters the GOP Congress has created. Probably our best hope is that one or many, like Shkreli, will overreach in an outrageous greed that our government has condoned for decades. Like errant spoiled children, pharmaceuticals (Pharma) have run roughshod over an obliging Congress and a consuming public since politicians -- in effect -- gave them license to steal.
- Pharmageddon
Resource Type: Book
Published: 2013
David Healy's comprehensive argument against the pharmaceuticalization of medicine is an indictment of problems in health care that are leading to a growing number of deaths and disabilities.
- Pharmageddon: how the US got hooked on prescription drugs
White House declares prescription drug abuse in US 'alarming' as thousands flock to Florida – the home of oxycodone pill mills
Resource Type: Article
Published: 2011
An investigation into the underground trade of oxycodone, a widely abused prescription drug. Ninety-eight percent of prescriptions in the United States come from southern Florida, where doctors at "pill-mills" can see up to one hundred patients in a sitting.
- Private Profits vs Public Policy
The Pharmaceutical Industry and the Canadian State
Resource Type: Book
Published: 2016
According to Joel Lexchin, "Given the central role that medicines play in keeping us healthy, it is essential that we understand the policy environment that governs drug development, from the initial basic research to the sale of the manufactured produces to the patients that use them."
- The Real Pushers
A Critical Analysis of the Canadian Drug Industry
Resource Type: Book
Published: 1984
A comprehensive analysis of the pharmaceutical drug industry in Canada.
- The Report of the Commission of Inquiry on the Pharmaceutical Industry.
Resource Type: Book
Published: 1972
- "Right to Try" Is a Cruel Farce
Resource Type: Article
Published: 2018
Drug companies want you to think they're providing glimmers of hope to terminally ill patients. Don't believe them.
- SNC-Lavalin Group Inc.
Media Profile in Sources
Resource Type: Organization
- Sources HotLink - June 30, 2016
Resource Type: Serial Publication (Periodical)
Published: 2016
Articles about the FBI and the information it gathers, Donald Trump and the media, and the role of pharmaceutical companies in suppressing information.
- Survey shows varying prices at drug store
Resource Type: Article
Published: 1976
It pays to shop around before you decide with which drug store to do business. This is the conclusion of a survey of Ward 7 drug stores carried out recently by Seven News staff.
- TPP is "Worst Trade Agreement" for Medicine Access, Says Doctors Without Borders
Resource Type: Article
Published: 2015
The TPP [Trans-Pacific Partnership] will…go down in history as the worst trade agreement for access to medicines in developing countries, said Doctors without Borders/Médecins Sans Frontières (MSF) in a statement following the signing of the TPP trade deal.
|
AlterLinks
© 2021.
|